GSK, Pennsylvania
GSK embarks on Pennsylvania manufacturing expansion worth up to $800M, creating 200 new jobs
After making a splash in the U.K. earlier this year, GSK is laying out plans for its biggest U.S. manufacturing investment yet. | In its biggest U.S. manufacturing investment yet, GSK is spending up to $800 million to double the size and capacity of its site in Marietta,
GSK (GSK) continued losses for a seventh straight session as the stock closed xx% lower, at $xx on Friday. The British ...
GlobalData on MSN2d
GSK pumps up to $800m for US manufacturing site upgradeA new vaccines drug substance facility and R&D pilot plant, completed by the end of 2028, will create over 200 new jobs.
The British pharma is making what it calls its largest U.S. manufacturing investment. Elsewhere, AbbVie expanded a ...
Haleon was spun off from GSK amid investor pressure, showing steady growth but facing debt concerns. See more about HLN stock ...
GSK plans to invest $800 million in its East Donegal Township vaccine packaging facility over the next four years in an ...
Shares of GSK PLC GSK inched up 0.52% to £14.56 Thursday, on what proved to be an all-around positive trading session for ...
GSK Plc’s experimental drug to treat a common inflammatory nasal condition showed positive results in two late-stage trials ...
Pharma with 3,674 puts trading, or 5x expected. Most active are 10/25 weekly 38 puts and Nov-24 40 calls, with ...
Shares of GSK PLC GSK inched down 0.72% to £14.54 Tuesday, on what proved to be an all-around dismal trading session for ...
GSK said it is making its largest manufacturing investment in the US yet, allocating $800 million to upgrade its vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback